Articole cu mandate pentru acces public - william t carpenterAflați mai multe
Nu sunt disponibile nicăieri: 4
Attenuated psychosis syndrome: ready for DSM-5.1?
P Fusar-Poli, WT Carpenter, SW Woods, TH McGlashan
Annual review of clinical psychology 10 (1), 155-192, 2014
Mandate: US National Institutes of Health
Endogenous oxytocin levels are associated with impaired social cognition and neurocognition in schizophrenia
GP Strauss, HC Chapman, WR Keller, JI Koenig, JM Gold, WT Carpenter, ...
Journal of Psychiatric Research 112, 38-43, 2019
Mandate: US National Institutes of Health, US Department of Veterans Affairs
Oxytocin and sexual function in males and females with schizophrenia
HJ Wehring, RW Buchanan, S Feldman, WT Carpenter, RP McMahon, ...
Schizophrenia Research 199, 431-432, 2018
Mandate: US National Institutes of Health
Original Research Participants With Schizophrenia Retain the Information
BA Fischer, RP McMahon, WA Meyer, DJ Slack, PS Appelbaum, ...
J Clin Psychiatry 74 (6), 622-627, 2013
Mandate: US National Institutes of Health
Disponibile undeva: 57
The Hierarchical Taxonomy of Psychopathology (HiTOP): A dimensional alternative to traditional nosologies.
R Kotov, RF Krueger, D Watson, TM Achenbach, RR Althoff, RM Bagby, ...
Journal of abnormal psychology 126 (4), 454, 2017
Mandate: UK Medical Research Council
The psychosis high-risk state: a comprehensive state-of-the-art review
P Fusar-Poli, S Borgwardt, A Bechdolf, J Addington, A Riecher-Rössler, ...
JAMA psychiatry 70 (1), 107-120, 2013
Mandate: US National Institutes of Health
Social cognition in schizophrenia: an NIMH workshop on definitions, assessment, and research opportunities
MF Green, DL Penn, R Bentall, WT Carpenter, W Gaebel, RC Gur, ...
Schizophrenia bulletin 34 (6), 1211-1220, 2008
Mandate: US National Institutes of Health
Definition and description of schizophrenia in the DSM-5
R Tandon, W Gaebel, DM Barch, J Bustillo, RE Gur, S Heckers, ...
Schizophrenia research 150 (1), 3-10, 2013
Mandate: UK Medical Research Council
Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology
OD Howes, R McCutcheon, O Agid, A De Bartolomeis, NJM Van Beveren, ...
American Journal of Psychiatry 174 (3), 216-229, 2017
Mandate: US National Institutes of Health, National Health and Medical Research …
Treatments of negative symptoms in schizophrenia: meta-analysis of 168 randomized placebo-controlled trials
P Fusar-Poli, E Papanastasiou, D Stahl, M Rocchetti, W Carpenter, ...
Schizophrenia bulletin 41 (4), 892-899, 2015
Mandate: National Institute for Health Research, UK
Preventive strategies for mental health
C Arango, CM Díaz-Caneja, PD McGorry, J Rapoport, IE Sommer, ...
The Lancet Psychiatry 5 (7), 591-604, 2018
Mandate: European Commission, Government of Spain
Progress in achieving quantitative classification of psychopathology
RF Krueger, R Kotov, D Watson, MK Forbes, NR Eaton, CJ Ruggero, ...
World psychiatry 17 (3), 282-293, 2018
Mandate: US National Institutes of Health, Netherlands Organisation for Scientific …
Deconstructing negative symptoms of schizophrenia: avolition–apathy and diminished expression clusters predict clinical presentation and functional outcome
GP Strauss, WP Horan, B Kirkpatrick, BA Fischer, WR Keller, P Miski, ...
Journal of psychiatric research 47 (6), 783-790, 2013
Mandate: US National Institutes of Health
Structure of the psychotic disorders classification in DSM‐5
S Heckers, DM Barch, J Bustillo, W Gaebel, R Gur, D Malaspina, ...
Schizophrenia research 150 (1), 11-14, 2013
Mandate: UK Medical Research Council
Catatonia in DSM-5
R Tandon, S Heckers, J Bustillo, DM Barch, W Gaebel, RE Gur, ...
Schizophrenia research 150 (1), 26-30, 2013
Mandate: UK Medical Research Council
Logic and justification for dimensional assessment of symptoms and related clinical phenomena in psychosis: relevance to DSM-5
DM Barch, J Bustillo, W Gaebel, R Gur, S Heckers, D Malaspina, ...
Schizophrenia research 150 (1), 15-20, 2013
Mandate: UK Medical Research Council
The evolution of drug development in schizophrenia: past issues and future opportunities
WT Carpenter, JI Koenig
Neuropsychopharmacology 33 (9), 2061-2079, 2008
Mandate: US National Institutes of Health
Schizophrenia—time to commit to policy change
WW Fleischhacker, C Arango, P Arteel, TRE Barnes, W Carpenter, ...
Schizophrenia bulletin 40 (Suppl_3), S165-S194, 2014
Mandate: Government of Spain
Validity and utility of hierarchical taxonomy of psychopathology (HiTOP): I. Psychosis superspectrum
R Kotov, KG Jonas, WT Carpenter, MN Dretsch, NR Eaton, MK Forbes, ...
World Psychiatry 19 (2), 151-172, 2020
Mandate: German Research Foundation
Attenuated psychosis syndrome in DSM-5
MT Tsuang, J Van Os, R Tandon, DM Barch, J Bustillo, W Gaebel, RE Gur, ...
Schizophrenia research 150 (1), 31-35, 2013
Mandate: US National Institutes of Health, UK Medical Research Council
Informațiile despre publicații și finanțare sunt alese automat de un program informatic